Chair of the Board of Directors
The Berlin Institute of Health at Charité (BIH) is led by a Board of Directors, responsible for strategic planning and implementation of the research program.
Professor Christopher Baum is the Chairman of the Board of Directors of the BIH. More information about Professor Baum can be found in his curriculum vitae.
The Extended Directorate consists of:
- Professor Axel R. Pries (Dean)
- four persons belonging to the full-time scientific staff of the Translational Research Unit.
The members according to sentence 1 number 2 are elected by the full-time scientific staff of the Translational Research Area for a period of three years.
The members will be announced shortly.
All activities of BIH are supervised by the Supervisory Board, which is also responsible for approving essential decisions such as the business plan, strategic planning, appointments, and investments.
|Deputies of the German Government|
|State Secretary Christian Luft||Federal Ministry of Education and Research, Chair|
|Dr. Jan Grapentin||Federal Ministry of Education and Research|
|Deputies of the federal state of Berlin|
|State Secretary Steffen Krach||Office of The Senate for Science, Deputy Chair|
|State Secretary Vera Junker||Senate Department for Finance, Berlin|
|Stefan Oelrich||Member of the Board of Management of Bayer AG|
|Joint Deputy of Freie Universität Berlin and Humboldt-Universität zu Berlin|
|Professor Günter M. Ziegler||President, Freie Universität Berlin|
|Deputy of the Helmholtz Association of German Research Centres|
|Professor Otmar D. Wiestler||President of the Helmholtz Association of German Research Centres|
|Professor Günter Stock||CEO, Einstein Foundation Berlin|
|Sonja Jost||Chief Executive Officer, DexLeChem GmbH|
|BIH Member from Charité – Universitätsmedizin Berlin|
|Professor Britta Siegmund||Director Medical Center for Gastroenterology, Infectiology and Rheumatology|
|BIH Member from the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association|
|Professor Claus Scheidereit||Coordinator Cancer Research at the MDC|
|Chair of the Scientific Advisory Board|
|Professor Lina Badimon||Institute for Cardiovascular Science, Barcelona, Spain|
Scientific Advisory Board
The Scientific Advisory Board is responsible for providing the Executive Board and Supervisory Board with external specialized knowledge regarding future important research topics and ongoing scientific and strategic issues; it meets every six months. At present the Scientific Advisory Board consists of thirteen international experts in translational research and systems medicine.
Chair of the Scientific Advisory Board
Prof. Lina Badimon
Institute for Cardiovascular Science, Barcelona, Spain
Dr. André Terzic
Mayo Clinic, USA
|Prof. Elizabeth Blackburn||Salk Institute for Biological Studies, La Jolla, USA|
|Prof. Alastair Buchan||Medical School und Medical Sciences Division, University of Oxford, England|
|Jan Geissler||Patvocates GmbH, Germany|
|Prof. Roland Lauster||TU Berlin, Germany|
|Prof. Teri Manolio||National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA|
|Prof. Miriam Merad||Mount Sinai School of Medicine, New York|
|Prof. Maritta Perälä-Heape||University of Oulu, Finland|
|Prof. Sibrand Poppema||Sunway University, Malaysia|
|Prof. Alan R. Shuldiner||University of Maryland School of Medicine, Baltimore, USA|
|Dr. Georg Schütte||Volkswagen Foundation, Germany|
|Prof. Fabian Theis||Helmholtz Zentrum München, Germany|